IRIS
VIGNERI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.190
EU - Europa 6.738
AS - Asia 6.249
SA - Sud America 1.021
AF - Africa 756
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 25.974
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.783
SG - Singapore 2.972
RU - Federazione Russa 2.062
IT - Italia 1.805
CN - Cina 1.515
BR - Brasile 856
IE - Irlanda 771
UA - Ucraina 589
VN - Vietnam 475
IN - India 471
CI - Costa d'Avorio 381
DE - Germania 311
CA - Canada 303
FR - Francia 283
KR - Corea 221
GB - Regno Unito 178
NL - Olanda 164
BD - Bangladesh 158
NG - Nigeria 132
SE - Svezia 117
SN - Senegal 116
BE - Belgio 111
FI - Finlandia 91
MX - Messico 69
AR - Argentina 67
IQ - Iraq 63
PL - Polonia 60
JP - Giappone 57
ES - Italia 45
HK - Hong Kong 44
CZ - Repubblica Ceca 37
TR - Turchia 35
UZ - Uzbekistan 35
ZA - Sudafrica 33
IR - Iran 27
BJ - Benin 24
CH - Svizzera 24
AE - Emirati Arabi Uniti 22
EC - Ecuador 22
VE - Venezuela 22
PK - Pakistan 21
CO - Colombia 20
ID - Indonesia 20
KE - Kenya 20
AT - Austria 17
GR - Grecia 17
SA - Arabia Saudita 17
MA - Marocco 14
IL - Israele 13
LB - Libano 12
MY - Malesia 12
CL - Cile 11
LT - Lituania 11
TN - Tunisia 11
AU - Australia 10
EG - Egitto 9
OM - Oman 9
JM - Giamaica 8
PY - Paraguay 8
RO - Romania 8
AZ - Azerbaigian 7
BG - Bulgaria 7
CR - Costa Rica 7
KZ - Kazakistan 7
RS - Serbia 7
AL - Albania 6
JO - Giordania 6
PH - Filippine 6
DO - Repubblica Dominicana 5
DZ - Algeria 5
PE - Perù 5
PS - Palestinian Territory 5
UY - Uruguay 5
BO - Bolivia 4
EU - Europa 4
HU - Ungheria 4
NP - Nepal 4
ET - Etiopia 3
GA - Gabon 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CG - Congo 2
HR - Croazia 2
LK - Sri Lanka 2
MN - Mongolia 2
PR - Porto Rico 2
TH - Thailandia 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CM - Camerun 1
Totale 25.959
Salva come PNG Salva come JPEG
Città #
Dallas 1.846
Singapore 1.797
Santa Clara 1.401
Moscow 932
Chandler 840
San Jose 821
Dublin 770
Jacksonville 647
Ashburn 602
Chicago 529
Catania 444
Abidjan 381
Boardman 342
Kochi 337
Hefei 335
Los Angeles 244
Lauterbourg 227
Seoul 220
Beijing 207
Cambridge 207
Lawrence 203
Nanjing 200
Andover 193
Toronto 168
New York 164
Ho Chi Minh City 148
Grafing 134
Dakar 116
Hanoi 114
Des Moines 112
Council Bluffs 111
San Mateo 100
Civitanova Marche 98
Buffalo 95
Wilmington 86
São Paulo 83
Milan 74
Palermo 69
Rotterdam 65
Lagos 64
Munich 63
Orem 63
Abuja 60
Ottawa 56
Rome 56
Tokyo 56
San Giovanni la Punta 53
Nanchang 51
Wingene 50
Montreal 48
Warsaw 48
Hebei 47
Shenyang 45
Bari 44
Lappeenranta 43
Chennai 42
Dong Ket 40
Hong Kong 40
Brooklyn 39
Saint Petersburg 38
Seattle 38
Brussels 37
Houston 36
Bremen 34
Portland 33
Amsterdam 32
Poplar 32
The Dalles 32
Changsha 30
Columbus 30
Jiaxing 30
Rio de Janeiro 30
Phoenix 29
Atlanta 28
Baghdad 28
Brno 28
Mexico City 27
Denver 26
Falls Church 26
Johannesburg 26
London 26
Tianjin 26
Boston 25
Turku 25
Cotonou 24
Manchester 23
San Francisco 23
Stockholm 23
Helsinki 22
Frankfurt am Main 21
Belo Horizonte 20
Tashkent 20
Messina 19
Pune 19
Florence 18
Brasília 17
Naples 17
Da Nang 16
Dhaka 16
Haiphong 16
Totale 17.536
Salva come PNG Salva come JPEG
Nome #
148P The impact of chemotherapy relative dose intensity on pathological complete response and event-free survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy 265
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications 250
Novel mechanisms of tumor promotion by the insulin receptor isoform a in triple-negative breast cancer cells 238
A Case of Non-Irradiated Balloon Cell Melanoma of the Choroid: Expanding the Morphological Spectrum of Primary Uveal Melanomas 229
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 227
Correlation between weight and Recurrence Score in a cohort of HR+ve/ HER2-ve early breast cancer patients: a retrospective analysis 219
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 207
Concordance between CDKN2A homozygous deletion and MTAP immunohistochemical loss in fluoroedenite-induced pleural mesothelioma: An immunohistochemical and molecular study on a single-institution series 204
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 192
Effect of low-dose tungsten on human thyroid stem/precursor cells and their progeny 178
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 175
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop 172
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 169
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 169
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 167
Biomarkers and prognostic factors for malignant pleural mesothelioma 167
Anaplastic thyroid cancer in sicily: The role of environmental characteristics. 167
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 164
Comparative proteomic analysis of insulin receptor isoform A and B signaling 162
Glioblastoma, IDH-Wild Type With FGFR3-TACC3 Fusion: When Morphology May Reliably Predict the Molecular Profile of a Tumor. A Case Report and Literature Review 159
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 158
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 158
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part I: MR imaging with pathologic correlation and technical considerations 154
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 154
A population-based study of chronic myeloid leukemia patients treated with imatinib in first line 151
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 149
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND FUNCTION OF INTERFERON REGULATORY FACTOR 5 (IRF-5) IN CHRONIC MYELOID LEUKEMIA CELLS 148
Histopathologic and mr imaging appearance of spontaneous and radiation-induced necrosis in uveal melanomas: Initial results 148
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells 147
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA 147
Diagnostic utility of the immunohistochemical expression of serin and arginine rich splicing factor 1 (Srsf1) in the differential diagnosis of adult gliomas 147
AN INSERTION IN THE BCR-ABL KINASE DOMAIN CONTRIBUTES TO IMATINIB MESYLATE RESISTANCE 146
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 145
Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging—Part II: treatment indications and complications 145
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review 144
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 144
BCR-ABL Tyrosine Kinase Activity Modulates the Phosphorylation, Localization and Function of Interferon Regulatory Factor 5 (irf-5) in Chronic Myeloid Leukemia (CML) Cells 143
Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release 141
BCR-ABL tyrosine kinase activity modulates the phosphorylation and the localization of Interferon Regulatory Factor 5 (IRF-5)in Chronic Myeloid Leukemia cells 141
New insights in thyroid cancer and p53 family proteins 141
Increased thyroid cancer incidence in volcanic areas: A role of increased heavy metals in the environment? 141
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery 141
Concentration of Metals and Trace Elements in the Normal Human and Rat Thyroid: Comparison with Muscle and Adipose Tissue and Volcanic Versus Control Areas 140
BCR-ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein 139
Mechanistic Translation of Melanoma Genetic Landscape in Enriched Pathways and Oncogenic Protein-Protein Interactions 137
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma 136
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 135
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 135
Insulin receptor isoforms differently regulate cell proliferation and apoptosis in the ligand‐occupied and unoccupied state 134
Heavy metals in the volcanic environment and thyroid cancer 133
Orbital metastasis from thyroid cancer: a case report and review of the literature 132
Heavy Metals in the Environment and Thyroid Cancer 132
Immunoexpression of p62/SQSTM1/Sequestosome-1 in human primary and recurrent IDH1/2 wild-type glioblastoma: A pilot study 130
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 130
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report 130
ENDOMETRIAL STROMAL TUMOR (SARCOMA) WITH LIMITED MIOMETRIAL INFILTRATION: A RARE CASE WITH PELVI-PERITONEAL METASTASES 130
Mr imaging–pathologic correlation of uveal melanomas undergoing secondary enucleation after proton beam radiotherapy 130
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer 130
Navigating the Nexus: HIV and Breast Cancer—A Critical Review 129
BCR-ABL TYROSINE KINASE ACTIVITY MODULATES THE PHOSPHORYLATION, LOCALIZATION AND BIOLOGICAL FUNCTION OF INTERFERON REGULATORY FACTOR 5 IN CHRONIC MYELOID LEUKEMIA CELLS 129
Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature 128
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 128
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 127
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 127
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 127
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 127
BCR-Abl tyrosine kinase activity modulates the expression of Interferon Regulatory Factor-5 in CML cells 126
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 126
Differences among young adults, adults and elderly chronic myeloid leukemia patients 125
The Consistency and Quality of ChatGPT Responses Compared to Clinical Guidelines for Ovarian Cancer: A Delphi Approach 124
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 124
Cerebellar liponeurocytoma: clinical, histopathological and molecular features of a series of three cases, including one recurrent tumor 122
A Multiplex Assay for Fast PIK3CA Hotspot Mutation Characterization in a Single Specimen by 3-Color Digital PCR Analysis 121
A new kid on the block: Sacituzumab govitecan for the treatment of breast cancer and other solid tumors 121
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 120
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression 120
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 119
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 119
BCR-ABL tyrosine kinase activity modulates survivin expression via PI3K/AKT 118
Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease 118
BCR-ABLIS Expression at Diagnosis and After 3 or 6 Months of Treatment Predicts CML Response to IMATINIB Therapy 117
Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 114
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 113
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 113
Suppression of survivin induced by BCR-ABL/JAK2/STAT3 pathway sensitizes imatinib-resistant CML cells to different cytotoxic drugs 112
Computational and Experimental Characterization of Two Nuclear Localization Signals and a Nuclear Export Signal that modulate BCR intracellular localization 112
BCR-ABL tyrosine kinase activity modulates Survivin expression in CML cells 112
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer 110
Uncommon long-term survival in a patient with chronic myeloid leukemia 110
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 110
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data 110
c-IAP1, Survivin and Smac contribute to chemotherapy resistance in undifferentiated thyroid cancer cells 109
The optimal timing between neoadjuvant therapy and surgery of breast cancer: a brief systematic review of the literature 108
Vg9Vd2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells 108
Early Gastrointestinal Progression to Immunotherapy in Lung Cancer: A Report of Two Cases 107
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis 104
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 103
Hypoxia Induces Imatinib Resistance in CML Cell Lines 103
Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer 102
Lipoblastoma-like tumor of the inguinal region: a close mimicker of myxoid liposarcoma 102
Totale 14.150
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 0 0 0 0 0 0 0 87
2021/20221.496 155 202 22 20 229 37 223 49 136 28 56 339
2022/20232.775 228 144 58 296 208 462 32 540 633 20 94 60
2023/20241.443 108 220 52 78 76 257 34 86 10 67 268 187
2024/20255.951 159 869 311 258 1.148 686 255 185 364 460 780 476
2025/202612.052 736 720 2.065 771 1.823 2.473 1.368 251 560 622 442 221
Totale 26.403